Klein-Edmonds Associates was started by Elizabeth Klein to address the recurrent lack of communication between SME BioScience businesses and the investment community.
Both want to reach the same goals – significant shareholder returns. Yet they are frequently stymied, not by their strategy or expected returns, but by the inability of the BioScience sector to successfully communicate to the investment community.
Elizabeth Klein started her career in scientific research but quickly entered the City. She spent over a decade as a highly regarded Investment Research analyst (in the Extel Survey) and was No 1 StockPicker in the Starmine Awards for the Healthcare Sector in 2006 and 2013 followed by an extensive period advising UK businesses and investors. She has experience in:
- business and investment analysis and valuation
- business relationship building and corporate advice
- engagement with the UK’s investment community
- strategic analysis, including advice to Board level.
Her areas of focus over the last two decades has been the Healthcare and Life Sciences, and the IP Commercialisation sectors.
“Klein-Edmonds Associates is passionate about helping companies access the right investment at the right time from the right investor.”